ArticleInternational journal of legal medicine2026
Quantitative assessment of the repeatability of PermaGel as a ballistic tissue simulant.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The awareness of economic, environmental and ethical considerations centred on replication of human tissue have increased in recent years. This has driven the need to find repeatable products which can be re-used without detriment to datasets whilst providing economic benefit to research programmes and reducing the quantity of material disposed of at the end of the trials phase. This study is focussed on the ability of PermaGel to provide a repeatable medium for both survivability and lethality applications when re-used continuously. A baseline series of tests were undertaken using a single stage gas gun, with the material samples then undergoing a series of melt/recast cycles before being tested again to examine any differences in performance. The results show that a 30.40% difference in depth of penetration was observed post thermal cycling of the material, whilst a 5.36% increase in the maximum diameter of the temporary cavity was also observed. These results have raised concerns on PermaGel's ability to be re-used accurately and recommendations on its use provided to ensure data inaccuracy risk is minimised. The findings herein have confirmed the concerns raised within the literature, provided the research community with a single point of source data, and recommended areas for future work to ensure continued characterisation is undertaken.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.